Pharmazz Inc
- Biotech or pharma, therapeutic R&D
Pharmazz has two FDA-approved Phase III INDs and one approved Phase II IND of first-in-class drug candidates. Sovateltide for stroke and Centhaquine for shock are approved for marketing in India. We partnered with Sun Pharma and Dr. Reddy’s Lab for India.